Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Hanlim Pharm. Co., Ltd. clinical trials
The registry lists 50 studies whose lead sponsor is Hanlim Pharm. Co., Ltd.. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 20, 2026.
Keep track of what changes. Save the Hanlim Pharm. Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Hanlim Pharm. Co., Ltd..
- Hanlim Pharm. Co., Ltd.50 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 50 of 50.
- Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes MellitusRecruitingNCT07552389Phase 3
- Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary DiseaseRecruitingNCT06434792Phase 2
- The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR TabRecruitingNCT06188234
- Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled InjectionRecruitingNCT06246331
- An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)RecruitingNCT06214832
- An Observational Study on the Identification of Prescription Patterns of STAFEN CapRecruitingNCT06204380
- Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye DropsRecruitingNCT06172530
- S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets AchievementRecruitingNCT06130124
- Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult VolunteersCompletedNCT07598968Phase 1
- Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting StateCompletedNCT07568652Phase 1
- Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.CompletedNCT06642987Phase 1
- Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult SubjectsCompletedNCT06475872Phase 1
- DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral NeuropathyCompletedNCT06191614
- Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic RetinopathyStatus unknownNCT05358080Phase 4
- Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)Status unknownNCT04882228Phase 4
- To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)CompletedNCT04606329Phase 3
- Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult VolunteersCompletedNCT04667624Phase 1
- To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary HypercholesterolemiaStatus unknownNCT04659070Phase 3
- Phase 2a Clinical Trial of HL237 for Rheumatoid ArthritisStatus unknownNCT04638426Phase 2
- The Study of Pharmacokinetic Interactions Between HL237 and TacrolimusStatus unknownNCT04633733Phase 1
- Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer PatientsStatus unknownNCT04632342Phase 2
- Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy VolunteersCompletedNCT04114461Phase 1
- Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With OsteoporosisCompletedNCT01675297Phase 4
- Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of KneeCompletedNCT01768520Phase 3
- To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast LesionsCompletedNCT03743259Phase 2
- A Multiple Dose of HL237 in Healthy Male SubjectStatus unknownNCT03896594Phase 1
- A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male SubjectsCompletedNCT03650608Phase 1
- A Dose-escalation Clinical Trial After Multiple Dosing of HL217 Eye Drop in Healthy Male SubjectsCompletedNCT03648346Phase 1
- A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis PatientsCompletedNCT03654196Phase 3
- To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis PatientsCompletedNCT03655210Phase 3
- To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic WomenCompletedNCT01904110Phase 4
- Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension GroupCompletedNCT01768312Phase 3
- Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus CutaneusCompletedNCT03317301Phase 3
- Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)CompletedNCT03648333Phase 1
- Repeated Dosing Clinical Trial of HL151CompletedNCT02686294Phase 1
- A Single Ascending Dose Clinical Trial to Find the Maximum Tolerable Dose of HL237 in Healthy Male SubjectCompletedNCT03278470Phase 1
- The Pharmacokinetic Interaction Between Celecoxib and RebamipideCompletedNCT01549743Phase 1
- Single Dosing Clinical Trial of HL151CompletedNCT02682745Phase 1
- Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary HypercholesterolemiaCompletedNCT03571087Phase 3
- A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemiaCompletedNCT03618797Phase 3
- The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin CaCompletedNCT02250976Phase 1
- Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and PitavastatinCompletedNCT01767610Phase 1
- Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)CompletedNCT01819779Phase 1
- A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis PatientsCompletedNCT03309800Phase 2
- Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male SubjectsCompletedNCT02955498Phase 1
- A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on)CompletedNCT02250027Phase 2
- Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye DiseaseCompletedNCT02229955Phase 3
- Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic RhinitisCompletedNCT01470053Phase 3
- Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male SubjectsCompletedNCT01652339Phase 1
- Post-menopausal Women Osteoporosis(Phase III)CompletedNCT01806792Phase 3